6,626 Shares in National HealthCare Corporation $NHC Bought by The Manufacturers Life Insurance Company

Key Points

• The Manufacturers Life Insurance Company purchased 6,626 shares of National HealthCare, valued at approximately $1.4 million. Institutional investors and hedge funds collectively own 56.44% of the company.
• Analyst sentiment is positive, with two firms rating NHC a “Strong Buy” and two assigning a “Hold” rating, resulting in a consensus “Buy” rating.
• National HealthCare reported quarterly earnings of $1.74 per share on $408.03 million in revenue and declared a quarterly dividend of $0.67, representing a 1.2% yield.

The Manufacturers Life Insurance Company purchased a new position in shares of National HealthCare Corporation (NYSEAMERICAN:NHC - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,626 shares of the company's stock, valued at approximately $1,400,000.

A number of other large investors have also recently added to or reduced their stakes in the company. Allworth Financial LP bought a new position in shares of National HealthCare in the 2nd quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of National HealthCare in the 2nd quarter valued at about $37,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of National HealthCare in the 3rd quarter valued at about $25,000. Quarry LP raised its holdings in shares of National HealthCare by 171.9% in the 3rd quarter. Quarry LP now owns 261 shares of the company's stock valued at $32,000 after purchasing an additional 165 shares during the period. Finally, Kestra Advisory Services LLC acquired a new stake in National HealthCare in the 4th quarter valued at about $42,000. Institutional investors and hedge funds own 56.44% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on NHC. Royal Bank Of Canada upgraded National HealthCare to a "hold" rating in a report on Monday, May 18th. BMO Capital Markets upgraded National HealthCare to a "hold" rating in a research note on Monday, May 18th. The Goldman Sachs Group raised National HealthCare to a "strong-buy" rating in a research report on Monday, May 18th. Finally, Robert W. Baird upgraded National HealthCare to a "strong-buy" rating in a research note on Monday, May 18th. Two research analysts have rated the stock with a Strong Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Buy".

National HealthCare Price Performance

NHC opened at $218.64 on Friday. The business has a fifty day simple moving average of $220.98 and a 200 day simple moving average of $191.71. The company has a market capitalization of $3.42 billion, a PE ratio of 24.59 and a beta of 0.62. National HealthCare Corporation has a 1 year low of $112.40 and a 1 year high of $239.29.

National HealthCare (NYSEAMERICAN:NHC - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $1.74 earnings per share for the quarter. The firm had revenue of $408.03 million for the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.

National HealthCare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.67 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $2.68 annualized dividend and a yield of 1.2%. National HealthCare's payout ratio is 61.89%.

Insider Transactions at National HealthCare

In other news, Director David R. Gifford sold 1,779 shares of the firm's stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $225.42, for a total transaction of $401,022.18. Following the transaction, the director directly owned 1,030 shares of the company's stock, valued at approximately $232,182.60. This trade represents a 63.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Stephen Fowler Flatt sold 1,500 shares of National HealthCare stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.08, for a total transaction of $355,620.00. Following the completion of the sale, the chief executive officer owned 65,487 shares of the company's stock, valued at approximately $15,525,657.96. The trade was a 2.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 13.92% of the company's stock.

National HealthCare Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source